Fridolin Hoesly, MD | |
2747 Ne Conners Ave, Bend, OR 97701 | |
(541) 382-5712 | |
Not Available |
Full Name | Fridolin Hoesly |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 15 Years |
Location | 2747 Ne Conners Ave, Bend, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285860288 | NPI | - | NPPES |
005622300 | Medicaid | FL | |
500677859 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | MD168020 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ohsu Hospital And Clinics | Portland, OR | Hospital |
St Charles Medical Center - Bend | Bend, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mountain West Derm - Blackhart Pllc | 1153609813 | 103 |
News Archive
Women undergoing treatment for breast cancer might fight off distressing side effects and improve psychological well-being by staying off the couch. According to the University of Miami (UM) study, women who are physically active during treatment have less depression and an enhanced quality of life and report less debilitating fatigue.
People with blood cancer are less likely to understand their diagnosis than those with any other type of cancer, according to a new analysis by Bloodwise.
Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that it has been awarded a grant by the United States government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its lead product CM-AT for autism. CM-AT is presently in Phase III clinical trials at 18 sites around the US.
nvestigators for The Cancer Genome Atlas Research Network have detailed and broadly classified the genomic alterations that frequently underlie the development of acute myeloid leukemia, a deadly cancer of the blood and bone marrow.
› Verified 1 days ago
Entity Name | Mountain West Derm - Blackhart Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447764741 PECOS PAC ID: 1153609813 Enrollment ID: O20171219002516 |
News Archive
Women undergoing treatment for breast cancer might fight off distressing side effects and improve psychological well-being by staying off the couch. According to the University of Miami (UM) study, women who are physically active during treatment have less depression and an enhanced quality of life and report less debilitating fatigue.
People with blood cancer are less likely to understand their diagnosis than those with any other type of cancer, according to a new analysis by Bloodwise.
Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that it has been awarded a grant by the United States government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its lead product CM-AT for autism. CM-AT is presently in Phase III clinical trials at 18 sites around the US.
nvestigators for The Cancer Genome Atlas Research Network have detailed and broadly classified the genomic alterations that frequently underlie the development of acute myeloid leukemia, a deadly cancer of the blood and bone marrow.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Fridolin Hoesly, MD 2747 Ne Conners Ave, Bend, OR 97701 Ph: (904) 953-2000 | Fridolin Hoesly, MD 2747 Ne Conners Ave, Bend, OR 97701 Ph: (541) 382-5712 |
News Archive
Women undergoing treatment for breast cancer might fight off distressing side effects and improve psychological well-being by staying off the couch. According to the University of Miami (UM) study, women who are physically active during treatment have less depression and an enhanced quality of life and report less debilitating fatigue.
People with blood cancer are less likely to understand their diagnosis than those with any other type of cancer, according to a new analysis by Bloodwise.
Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that it has been awarded a grant by the United States government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its lead product CM-AT for autism. CM-AT is presently in Phase III clinical trials at 18 sites around the US.
nvestigators for The Cancer Genome Atlas Research Network have detailed and broadly classified the genomic alterations that frequently underlie the development of acute myeloid leukemia, a deadly cancer of the blood and bone marrow.
› Verified 1 days ago
Dr. Oliver Jayme Wisco, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: Dermatology Health Spcecialist, 1693 Sw Chandler Ave Suite 250, Bend, OR 97702 Phone: 541-382-8819 | |
William J Delgado, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2705 Ne Conners Ave, Bend, OR 97701 Phone: 541-382-5712 Fax: 541-382-2605 | |
Dr. Stephanie Alice Trautman, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2747 Ne Conners Ave, Bend, OR 97701 Phone: 541-382-5712 | |
Dr. Andrew O Jensen, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1501 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-2811 | |
Dr. James Michael Hoesly, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 2600 Ne Neff Rd, Bend, OR 97701 Phone: 541-322-3504 | |
Mrs. Jill M Olinger, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 815 Sw Bond St, Bend, OR 97702 Phone: 541-382-2811 |